Temi della conferenza Overcome the translational challenges limiting the development of the next generation of CKD therapeutics. For the 3rd year, the Chronic Kidney Disease Drug Development Summit (CKD3) is putting the hottest topics in CKD drug development under the spotlight.
Speakers: Andrew King, Head of Renal Discovery and Translational Medicine, Chinook Therapeutics, Beno Freedman, Assistant Professor, Nephrology, University of Washington and more.
